3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Uterine Cervical Neoplasms
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Recurrence
1
Lung Neoplasms
1
Leiomyoma
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
16
Cetuximab
16
Radiotherapy, Intensity-Modulated
10
Radiotherapy
7
Docetaxel
7
Fluorouracil
5
Erlotinib Hydrochloride
5
Everolimus
4
Carboplatin
4
Sorafenib
3
Paclitaxel
3
Fluorodeoxyglucose F18
3
Chemotherapy, Adjuvant
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
Ultrasonography
2
Taxes
2
Sirolimus
2
Radiotherapy, Conformal
2
Radiation
2
Platinum
2
Photochemotherapy
2
Magnetic Resonance Spectroscopy
2
Cryosurgery
2
Celecoxib
2
Biopsy
2
Bevacizumab
2
1-phenyl-3,3-dimethyltriazene
2
1,2-diaminocyclohexaneplatinum II citrate
2
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Tongue Neoplasms
×
DMAC2L protein, human
×
Clear all
NCT02748707
2022-04-28
ERLO-XIB
Tata Memorial Hospital
Phase 2
Unknown
64 enrolled